Aspirin prevents Preeclampsia and related Morbidity and Mortality: USPSTF

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-09-30 03:30 GMT | Update On 2021-09-30 04:24 GMT

US Preventive Services Task Force updated its 2014 recommendation as published in the JAMA and commissioned a systematic review to evaluate the effectiveness of low-dose aspirin use to prevent preeclampsia.

Pregnant persons at high risk for preeclampsia who have no prior adverse effects with or contraindications to low-dose aspirin were selected.

The USPSTF concludes with moderate certainty that there is a substantial net benefit of daily low-dose aspirin use to reduce the risk for preeclampsia, preterm birth, small for gestational age/intrauterine growth restriction, and perinatal mortality in pregnant persons at high risk for preeclampsia.

Below is the summary of the recommendations:

· Preeclampsia is one of the most serious health problems that affect pregnant persons.

· It is a multisystem inflammatory syndrome that is often progressive but has an unclear aetiology.

· Worldwide, preeclampsia is the second most common cause of maternal morbidity and mortality.

· It is a complication in approximately 4% of pregnancies in the US and contributes to both maternal and infant morbidity and mortality.

· Preeclampsia also accounts for 6% of preterm births and 19% of medically indicated preterm births in the US.

· There are racial and ethnic disparities in the prevalence of and mortality from preeclampsia.

· Non-Hispanic Black women are at greater risk for developing preeclampsia than other women and experience higher rates of maternal and infant morbidity and perinatal mortality than other racial and ethnic groups.

· In the US, the rate of maternal death from preeclampsia is higher among non-Hispanic Black women than non-Hispanic White women.

· Disparities in risk factors for preeclampsia, access to early prenatal care, and obstetric interventions may account for some of the differences in prevalence and clinical outcomes.

· These disparities largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status

Reference:

Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement

doi:10.1001/jama.2021.14781

Article Source : JAMA

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Aspirin prevents Preeclampsia and related Morbidity and Mortality: USPSTF

Similar News

Clinical Practice Guidelines for Assessment, Management, and Treatment of Eating Disorders During Perinatal Period

Updated Guidelines on Amniocentesis and Chorionic Villus Sampling: Key Recommendations for Safe Prenatal Diagnosis

New Guidelines Affirm Role of Antenatal Corticosteroids in Reducing Neonatal Complications

New Green-top Guidelines Address Effective Management of Pregnancy-Related Nausea and Vomiting

WHO Issues Updated Guidelines for Managing Non-Severe Hypertension in Pregnancy

ACOG Issues Evidence-Based Guidelines for Managing First and Second Stages of Labor

New recommendations for screening and treatment of postpartum depression

Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline